GT Biopharma, Inc. (GTBP) Ownership

$0.00

$0 (0%)
Last update: 07:00 PM EST
Day's range
$0.42
Day's range
$0.46

GT Biopharma Inc Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
VANGUARD CAPITAL MANAGEMENT LLC 08/13/2026 376.40 K $184.44 K   -16.70% 1.24%
GEODE CAPITAL MANAGEMENT, LLC 08/12/2026 266.79 K $130.65 K   -9.40% 0.88%
VANGUARD FIDUCIARY TRUST CO 08/13/2026 225.94 K $110.71 K   0.00% 0.75%
HRT FINANCIAL LP 08/14/2026 107.14 K $52.00 K   100.00% 0.35%
EVERHART FINANCIAL GROUP, INC. 07/09/2026 100.00 K $48.97 K   100.00% 0.33%
SRS CAPITAL ADVISORS, INC. 08/10/2026 93.63 K $45.85 K   0.00% 0.31%
OPAL WEALTH ADVISORS, LLC 07/20/2026 81.81 K $40.06 K   100.00% 0.27%
NORTHERN TRUST CORP 08/13/2026 75.46 K $36.95 K   100.00% 0.25%
49 WEALTH MANAGEMENT, LLC 08/18/2026 64.00 K $31.34 K   100.00% 0.21%
ALONGSIDE, LLC 08/14/2026 64.00 K $31.34 K   100.00% 0.21%
CETERA INVESTMENT ADVISERS 08/12/2026 55.94 K $27.39 K   100.00% 0.18%
SEACREST WEALTH MANAGEMENT, LLC 07/09/2026 50.10 K $24.53 K   0.20% 0.17%
KITCHING PARTNERS, LLC 07/30/2026 50.00 K $24.49 K   100.00% 0.17%
INTEGRATED WEALTH CONCEPTS LLC 08/12/2026 40.01 K $19.59 K   100.00% 0.13%
PNC FINANCIAL SERVICES GROUP, INC. 08/07/2026 40.00 K $19.60 K   100.00% 0.13%
ADVISOR GROUP HOLDINGS, INC. 08/14/2026 38.50 K $18.86 K   83.33% 0.13%
LPL FINANCIAL LLC 08/07/2026 36.38 K $17.82 K   19.74% 0.12%
STONEX GROUP INC. 08/12/2026 23.26 K $8.67 K   57.62% 0.08%
MORGAN STANLEY 08/13/2026 22.57 K $11.05 K   35.99% 0.07%
KEEL POINT, LLC 08/14/2026 20.77 K $10.17 K   0.00% 0.07%
CI PRIVATE WEALTH, LLC 08/17/2026 20.00 K $10.00 K   100.00% 0.07%
PRIVATE WEALTH MANAGEMENT GROUP, LLC 07/27/2026 20.00 K $9.79 K   0.00% 0.07%
SAGESPRING WEALTH PARTNERS, LLC 08/03/2026 20.00 K $9.79 K   100.00% 0.07%
COSTON, MCISAAC & PARTNERS 08/12/2026 17.09 K $8.00 K   0.00% 0.06%
CAITLIN JOHN, LLC 08/17/2026 16.50 K $8.08 K   0.00% 0.05%
WELLS FARGO & COMPANY/MN 08/14/2026 15.99 K $7.83 K   -0.32% 0.05%
TEMPUS WEALTH PLANNING, LLC 07/22/2026 15.00 K $7.35 K   100.00% 0.05%
AM INVESTMENT STRATEGIES LLC 07/16/2026 15.00 K $7.00 K   0.00% 0.05%
TWO SIGMA SECURITIES, LLC 08/14/2026 13.39 K $6.56 K   -57.90% 0.04%
PROSPERA FINANCIAL SERVICES INC 07/15/2026 12.50 K $6.12 K   4.20% 0.04%
VERDENCE CAPITAL ADVISORS LLC 07/29/2026 12.00 K $5.88 K   0.00% 0.04%
MAYFLOWER FINANCIAL ADVISORS, LLC 07/09/2026 11.00 K $5.39 K   100.00% 0.04%
LASALLE ST. INVESTMENT ADVISORS, LLC 08/11/2026 11.00 K $5.39 K   0.00% 0.04%
PARSONS CAPITAL MANAGEMENT INC/RI 07/24/2026 10.90 K $5.34 K   0.00% 0.04%
KOSS-OLINGER CONSULTING, LLC 08/10/2026 10.00 K $4.90 K   100.00% 0.03%
NORTH STAR ASSET MANAGEMENT INC 08/18/2026 10.00 K $4.90 K   100.00% 0.03%
HBK SORCE ADVISORY LLC 08/06/2026 10.00 K $3.18 K   0.00% 0.03%
BLACKROCK, INC. 08/07/2026 8.31 K $4.07 K   -1.14% 0.03%
ROYAL BANK OF CANADA 08/14/2026 7.60 K $4.00 K   100.00% 0.03%
ATLANTIC UNION BANKSHARES CORP 08/11/2026 5.35 K $2.62 K   100.00% 0.02%
ALLWORTH FINANCIAL LP 08/11/2026 4.50 K $2.21 K   0.00% 0.01%
NEWBRIDGE FINANCIAL SERVICES GROUP, INC. 08/14/2026 3.75 K $1.84 K   0.00% 0.01%
MASSMUTUAL TRUST CO FSB/ADV 07/02/2026 3.00 K $1.47 K   0.00% 0.01%
FARTHER FINANCE ADVISORS, LLC 07/17/2026 3.00 K $1.47 K   0.00% 0.01%
WEST FINANCIAL ADVISORS, LLC 07/08/2026 2.50 K $1.23 K   0.00% 0.01%
STONE HOUSE INVESTMENT MANAGEMENT, LLC 08/05/2026 2.04 K $1.00 K   63.31% 0.01%
TOWER RESEARCH CAPITAL LLC (TRC) 08/11/2026 1.70 K $831   -0.12% 0.01%
TRIUMPH CAPITAL MANAGEMENT 07/21/2026 1.66 K $810   0.00% 0.01%
JONES FINANCIAL COMPANIES LLLP 08/14/2026 1.50 K $645   100.00% 0.01%
BARCLAYS PLC 08/14/2026 1.44 K $706   100.00% 0.00%

GT Biopharma Inc institutional Ownership - FAQ's

During the previous two years, 71 institutional investors and hedge funds held shares of GT Biopharma Inc. The most heavily invested institutionals were:

VANGUARD CAPITAL MANAGEMENT LLC: 376,399

GEODE CAPITAL MANAGEMENT, LLC: 266,788

VANGUARD FIDUCIARY TRUST CO: 225,938

HRT FINANCIAL LP: 107,140

Everhart Financial Group, Inc.: 100,000

SRS Capital Advisors, Inc.: 93,627

7.01% of GT Biopharma Inc stock is owned by institutional investors.

Institutional investors have bought a total of 2.14 M shares in the last 24 months. This purchase volume represents approximately $897.73 K in transactions.